Clinical Trial Update: Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing oral or intravenous thiazides to tolvaptan in diuretic-resistant decompensated heart failure has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• thiazides (oral or intravenous) (thiazide)
• tolvaptan (tolvaptan)

Snippet

Sponsor: Vanderbilt University | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2019-11-08